1
|
Bao K, Yoon JS, Ahn S, Lee JH, Cross CJ, Jeong MY, Frangioni JV, Choi HS. A robotic system for automated chemical synthesis of therapeutic agents. MATERIALS ADVANCES 2024; 5:5290-5297. [PMID: 38894709 PMCID: PMC11181120 DOI: 10.1039/d4ma00099d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/02/2024] [Accepted: 04/29/2024] [Indexed: 06/21/2024]
Abstract
The development of novel compounds for tissue-specific targeting and imaging is often impeded by a lack of lead compounds and the availability of reliable chemistry. Automated chemical synthesis systems provide a potential solution by enabling reliable, repeated access to large compound libraries for screening. Here we report an integrated solid-phase combinatorial chemistry system created using commercial and customized robots. Our goal is to optimize reaction parameters, such as varying temperature, shaking, microwave irradiation, aspirating and dispensing large-sized solid beads, and handling different washing solvents for separation and purification. This automated system accommodates diverse chemical reactions such as peptide synthesis and conventional coupling reactions. To confirm its functionality and reproducibility, 20 nerve-specific contrast agents for biomedical imaging were systematically and repeatedly synthesized and compared to other nerve-targeted agents using molecular fingerprinting and Uniform Manifold Approximation and Projection, which lays the foundation for creating reliable and reproductive chemical libraries in bioimaging and nanomedicine.
Collapse
Affiliation(s)
- Kai Bao
- Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School Boston MA 02114 USA
- Center for Molecular Imaging, Department of Medicine, Beth Israel Deaconess Medical Center Boston MA 02215 USA
| | - Jong Seo Yoon
- Center for Molecular Imaging, Department of Medicine, Beth Israel Deaconess Medical Center Boston MA 02215 USA
| | - Sung Ahn
- Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School Boston MA 02114 USA
| | - Jeong Heon Lee
- Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School Boston MA 02114 USA
- Center for Molecular Imaging, Department of Medicine, Beth Israel Deaconess Medical Center Boston MA 02215 USA
| | - Conor J Cross
- Center for Molecular Imaging, Department of Medicine, Beth Israel Deaconess Medical Center Boston MA 02215 USA
| | - Myung Yung Jeong
- Center for Molecular Imaging, Department of Medicine, Beth Israel Deaconess Medical Center Boston MA 02215 USA
- Department of Cogno-Mechatronics Engineering, Pusan National University Busan 46241 South Korea
| | - John V Frangioni
- Center for Molecular Imaging, Department of Medicine, Beth Israel Deaconess Medical Center Boston MA 02215 USA
- Curadel, LLC Natick MA 01760 USA
| | - Hak Soo Choi
- Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School Boston MA 02114 USA
- Center for Molecular Imaging, Department of Medicine, Beth Israel Deaconess Medical Center Boston MA 02215 USA
| |
Collapse
|
2
|
Zietek BM, Still KBM, Jaschusch K, Bruyneel B, Ariese F, Brouwer TJF, Luger M, Limburg RJ, Rosier JC, V Iperen DJ, Casewell NR, Somsen GW, Kool J. Bioactivity Profiling of Small-Volume Samples by Nano Liquid Chromatography Coupled to Microarray Bioassaying Using High-Resolution Fractionation. Anal Chem 2019; 91:10458-10466. [PMID: 31373797 PMCID: PMC6706796 DOI: 10.1021/acs.analchem.9b01261] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
![]()
High-throughput
screening platforms for the identification of bioactive
compounds in mixtures have become important tools in the drug discovery
process. Miniaturization of such screening systems may overcome problems
associated with small sample volumes and enhance throughput and sensitivity.
Here we present a new screening platform, coined picofractionation
analytics, which encompasses microarray bioassays and mass spectrometry
(MS) of components from minute amounts of samples after their nano
liquid chromatographic (nanoLC) separation. Herein, nanoLC was coupled
to a low-volume liquid dispenser equipped with pressure-fed solenoid
valves, enabling 50-nL volumes of column effluent (300 nL/min) to
be discretely deposited on a glass slide. The resulting fractions
were dried and subsequently bioassayed by sequential printing of nL-volumes
of reagents on top of the spots. Unwanted evaporation of bioassay
liquids was circumvented by employing mineral oil droplets. A fluorescence
microscope was used for assay readout in kinetic mode. Bioassay data
were correlated to MS data obtained using the same nanoLC conditions
in order to assign bioactives. The platform provides the possibility
of freely choosing a wide diversity of bioassay formats, including
those requiring long incubation times. The new method was compared
to a standard bioassay approach, and its applicability was demonstrated
by screening plasmin inhibitors and fibrinolytic bioactives from mixtures
of standards and snake venoms, revealing active peptides and coagulopathic
proteases.
Collapse
Affiliation(s)
- Barbara M Zietek
- Division of BioAnalytical Chemistry, Amsterdam Institute of Molecules, Medicines and Systems , Vrije Universiteit Amsterdam , Amsterdam 1081 HZ , The Netherlands
| | - Kristina B M Still
- Division of BioAnalytical Chemistry, Amsterdam Institute of Molecules, Medicines and Systems , Vrije Universiteit Amsterdam , Amsterdam 1081 HZ , The Netherlands
| | - Kevin Jaschusch
- Division of BioAnalytical Chemistry, Amsterdam Institute of Molecules, Medicines and Systems , Vrije Universiteit Amsterdam , Amsterdam 1081 HZ , The Netherlands
| | - Ben Bruyneel
- Division of BioAnalytical Chemistry, Amsterdam Institute of Molecules, Medicines and Systems , Vrije Universiteit Amsterdam , Amsterdam 1081 HZ , The Netherlands
| | - Freek Ariese
- LaserLaB , Vrije Universiteit Amsterdam , Amsterdam 1081 HZ , The Netherlands
| | - Tinco J F Brouwer
- Electronic Engineering , Vrije Universiteit Amsterdam , Amsterdam 1081 HZ , The Netherlands
| | - Matthijs Luger
- Electronic Engineering , Vrije Universiteit Amsterdam , Amsterdam 1081 HZ , The Netherlands
| | - Rob J Limburg
- Electronic Engineering , Vrije Universiteit Amsterdam , Amsterdam 1081 HZ , The Netherlands
| | - Joost C Rosier
- Fine Mechanics and Engineering Beta-VU , Vrije Universiteit Amsterdam , Amsterdam 1081 HZ , The Netherlands
| | - Dick J V Iperen
- Fine Mechanics and Engineering Beta-VU , Vrije Universiteit Amsterdam , Amsterdam 1081 HZ , The Netherlands
| | - Nicholas R Casewell
- Centre for Snakebite Research & Interventions , Liverpool School of Tropical Medicine , Pembroke Place , Liverpool L3 5QA , U.K.,Centre for Drugs and Diagnostics , Liverpool School of Tropical Medicine , Pembroke Place , Liverpool L3 5QA , U.K
| | - Govert W Somsen
- Division of BioAnalytical Chemistry, Amsterdam Institute of Molecules, Medicines and Systems , Vrije Universiteit Amsterdam , Amsterdam 1081 HZ , The Netherlands
| | - Jeroen Kool
- Division of BioAnalytical Chemistry, Amsterdam Institute of Molecules, Medicines and Systems , Vrije Universiteit Amsterdam , Amsterdam 1081 HZ , The Netherlands
| |
Collapse
|
3
|
Abstract
Speed and throughput are vital ingredients for discovery driven, "-omics" research. The small molecule microarray (SMM) succeeds at delivering phenomenal screening throughput and versatility. The concept at the heart of the technology is elegant, yet simple: by presenting large collections of molecules in high density on a flat surface, one is able to interrogate all possible interactions with desired targets, in just a single step. SMMs have become established as the choice platform for screening, lead discovery, and molecular characterization. This introduction describes the principles governing microarray construction and use, focusing on practical challenges faced when conducting SMM experiments. It will explain the key design considerations and lay the foundation for the chapters that follow. (An earlier version of this chapter appeared in Small Molecule Microarrays: Methods and Protocols, published in 2010.).
Collapse
Affiliation(s)
- Mahesh Uttamchandani
- Defence Medical and Environmental Research Institute, DMERI, DSO National Laboratories, #09-01, 27 Medical Drive, Singapore, Singapore, 117510. .,Department of Chemistry, Faculty of Science, National University of Singapore, 3 Science Drive 3, Singapore, Singapore, 117543.
| | - Shao Q Yao
- Department of Chemistry, Faculty of Science, National University of Singapore, 3 Science Drive 3, Singapore, Singapore, 117543.
| |
Collapse
|
4
|
Jonczyk R, Kurth T, Lavrentieva A, Walter JG, Scheper T, Stahl F. Living Cell Microarrays: An Overview of Concepts. MICROARRAYS (BASEL, SWITZERLAND) 2016; 5:E11. [PMID: 27600077 PMCID: PMC5003487 DOI: 10.3390/microarrays5020011] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/30/2016] [Revised: 05/09/2016] [Accepted: 05/11/2016] [Indexed: 02/06/2023]
Abstract
Living cell microarrays are a highly efficient cellular screening system. Due to the low number of cells required per spot, cell microarrays enable the use of primary and stem cells and provide resolution close to the single-cell level. Apart from a variety of conventional static designs, microfluidic microarray systems have also been established. An alternative format is a microarray consisting of three-dimensional cell constructs ranging from cell spheroids to cells encapsulated in hydrogel. These systems provide an in vivo-like microenvironment and are preferably used for the investigation of cellular physiology, cytotoxicity, and drug screening. Thus, many different high-tech microarray platforms are currently available. Disadvantages of many systems include their high cost, the requirement of specialized equipment for their manufacture, and the poor comparability of results between different platforms. In this article, we provide an overview of static, microfluidic, and 3D cell microarrays. In addition, we describe a simple method for the printing of living cell microarrays on modified microscope glass slides using standard DNA microarray equipment available in most laboratories. Applications in research and diagnostics are discussed, e.g., the selective and sensitive detection of biomarkers. Finally, we highlight current limitations and the future prospects of living cell microarrays.
Collapse
Affiliation(s)
- Rebecca Jonczyk
- Institute of Technical Chemistry, Leibniz University of Hannover, Callinstr. 5, Hannover 30167, Germany.
| | - Tracy Kurth
- Institute of Technical Chemistry, Leibniz University of Hannover, Callinstr. 5, Hannover 30167, Germany.
| | - Antonina Lavrentieva
- Institute of Technical Chemistry, Leibniz University of Hannover, Callinstr. 5, Hannover 30167, Germany.
| | - Johanna-Gabriela Walter
- Institute of Technical Chemistry, Leibniz University of Hannover, Callinstr. 5, Hannover 30167, Germany.
| | - Thomas Scheper
- Institute of Technical Chemistry, Leibniz University of Hannover, Callinstr. 5, Hannover 30167, Germany.
| | - Frank Stahl
- Institute of Technical Chemistry, Leibniz University of Hannover, Callinstr. 5, Hannover 30167, Germany.
| |
Collapse
|